Annis Gardner Whiting Capital Advisors, LLC Bristol Myers Squibb CO Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $279 Billion
- Q1 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 52 shares of BMY stock, worth $2,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 90
42.22%
Holding current value
$2,124
Previous $4.64 Million
39.31%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,557Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.6 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.64 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.74 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.63 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.87 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $86.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...